Trial Condition(s):

Liver Disease

Hepatic Impairment Study

Bayer Identifier:

12349

ClinicalTrials.gov Identifier:

NCT00829231

EudraCT Number:

Not Available

Study Completed

Trial Purpose

This study is to find out how the subject's body processes and reacts to the study drug, and to find out how long it remains in the subjects system after one dose. Subjects with varying degrees of liver function are being asked to participate in this study. Study results from subjects with normal liver function will be compared with study results from subjects with impaired liver function.

Inclusion Criteria
:
 - Healthy Subjects, Child Pugh A and Child Pugh B Liver Disease Patients.
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
45
Trial Dates
black-arrow
Phase
1
Could I receive a placebo?
No
Products
Nexavar (Sorafenib, BAY43-9006)
Accepts Healthy Volunteers
Yes

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Clinical Pharmacology of Miami, Inc.

Miami, United States, 33014

Status
Completed
 
Locations

Orlando Clinical Research Center

Orlando, United States, 32809

Status
Completed
 
Locations

New Orleans Center for Clinical Research

Knoxville, United States, 37920

Status
Completed
 

Trial Design